Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome
Renal disease is the most important long-term complication of hemolytic-uremic syndrome (HUS). A comparative study of renal function was carried out in two groups of patients. Group 1 included 19 children followed for a median of 11 years, 1960-1980, with a low-sodium diet, antihypertensive drugs, a...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2004
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 14995caa a22015137a 4500 | ||
|---|---|---|---|
| 001 | PAPER-21173 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205236.0 | ||
| 008 | 190411s2004 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-4844228028 | |
| 024 | 7 | |2 cas |a creatinine, 19230-81-0, 60-27-5; enalapril, 75847-73-3; furosemide, 54-31-9; prazosin, 19216-56-9, 19237-84-4; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a PEDNE | ||
| 100 | 1 | |a Caletti, M.G. | |
| 245 | 1 | 0 | |a Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome |
| 260 | |c 2004 | ||
| 270 | 1 | 0 | |m Caletti, M.G.; Servicio de Nefrología, Hosp. de Pediatria Juan P. Garrahan, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Gianantonio, C.A., Vitacco, M., Mendilaharzu, F., Gallo, G.E., Sojo, E.T., The hemolytic-uremic syndrome (1973) J. Pediatr., 118, pp. 191-194 | ||
| 504 | |a Spizirri, F.D., Arman, R.C., Bibiloni, N., Ruscasso, J.D., Amoreo, O.R., Childhood hemolytic uremic syndrome in Argentina: Long-term follow-up and prognostic features (1997) Pediatr. Nephrol., 11, pp. 156-160 | ||
| 504 | |a Kelles, A., Van Dyck, M., Proesmans, W., Childhood haemolytic uraemic syndrome: Long-term outcome and prognostic features (1994) Eur. J. Pediatr., 153, pp. 38-42 | ||
| 504 | |a Mendilaharzu, F., Caletti, M.G., Gómez, E.M., Epidemiology of chronic renal failure (CRF). Period 1987-1989 Collaborative study of ALANEPE, report of Argentina (1992) Pediatr. Res., 32, p. 741. , (abstract) | ||
| 504 | |a Bassani, C.E., Ferraris, J., Gianantonio, C.A., Ruiz, S., Ramirez, J., Renal transplantation in patients with classical hemolytic-uremic syndrome (1991) Pediatr. Nephrol., 5, pp. 607-611 | ||
| 504 | |a Repetto, H.A., Vazquez, L.A., Calvo, P., Palti, G., Renal transplantation in children with idiopathic "classic" hemolytic uremic syndrome (1989) Pediatr. Nephrol., 3, pp. C185. , (abstract) | ||
| 504 | |a Gianantonio, C.A., Vitacco, M., Mendilaharzu, F., Rutty, A., Mendilaharzu, J., The hemolytic uremic syndrome (1964) J. Pediatr., 4, pp. 478-491 | ||
| 504 | |a Royer, P., Habib, R., Mathieu, H., La microangiopathie thrombotique du rein chez l'enfant (1960) Ann. Pediatr., 36, pp. 572-576 | ||
| 504 | |a Loirat, C., Sonsino, E., Varga Moreno, A., Oillio, G., Mercier, J.C., Baufils, F., Mathieu, H., Hemolytic-uremic syndrome: An analysis of the natural history and prognostic features (1984) Acta Paediatr. Scand., 73, pp. 505-514 | ||
| 504 | |a Recommended dietary allowances (1989), Committee on Dietary Allowances National Academy of Science, Washington D.C; Blood pressure control in children (1984) Pediatrics, 79, pp. 1-25. , National Heart Lung and Blood Institute's Task Force. Betheseda, Maryland | ||
| 504 | |a Schwartz, G.J., Haycock, G.B., Edelmann Jr., C.M., Spitzer, A., A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine (1976) Pediatrics, 58, pp. 259-263 | ||
| 504 | |a Schwartz, G.J., Haycock, G.B., Chir, B., Plasma creatinine and urea concentration in children: Normal values for age and sex (1976) J. Pediatr., 88, pp. 828-830 | ||
| 504 | |a Mitch, W.E., Walser, M., Buffington, G.A., Lemann, J., Walker, M., A simple method of estimating progression of chronic renal failure (1976) Lancet, 2, pp. 1326-1332 | ||
| 504 | |a Gianantonio, C., Vitacco, M., Mendilaharzu, F., Gallo, G.E., Hemolytic-uremic syndrome. Renal status of 76 patients at long-term follow-up (1968) J. Pediatr., 72, pp. 757-765 | ||
| 504 | |a Moghal, N.E., Ferreira, M.A.S., Howie, A.J., Milford, D.V., Raafat, F., Taylor, C.M., The late histologic findings in diarrhea-associated hemolytic uremic syndrome (1968) J. Pediatr., 133, pp. 220-223 | ||
| 504 | |a Caletti, M.G., Gallo, G., Gianantonio, C.A., Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome (1996) Pediatr. Nephrol., 10, pp. 687-692 | ||
| 504 | |a Brenner, B.M., Meyer, T.W., Hostetter, T.H., Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease (1982) N. Engl. J. Med., 307, pp. 652-659 | ||
| 504 | |a George, G.R.P., Hickman, R.O., Stricker, G.F., Infantile nephritic syndrome (1976) Clin. Nephrol., 5, pp. 20-24 | ||
| 504 | |a Cotran, R.S., Nephrology forum: Glomerulosclerosis in reflux nephropathy (1982) Kidney Int., 21, pp. 528-534 | ||
| 504 | |a Kiprov, D.D., Colvin, R.B., McCluskey, R.T., Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis (1982) Lab. Invest., 46, pp. 275-281 | ||
| 504 | |a Douglas, S., Lox, J.A., Benstein, E.T., Dworkin, L.D., Effects, of salt restriction on renal growth and glomerular injury in rats with remnant kidneys (1992) Kidney Int., 41, pp. 1527-1534 | ||
| 504 | |a Benstein, J.A., Feiner, H.D., Parker, M., Dworkin, L.D., Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR (1990) Am. J. Physiol., 258, pp. F1675-F1681 | ||
| 504 | |a Wassner, S.J., Altered growth and protein turnover in rats fed sodium-deficient diets (1989) Pediatr. Res., 26, pp. 608-613 | ||
| 504 | |a Haycock, G.B., The influence of sodium on growth in infancy (1993) Pediatr. Nephrol., 7, pp. 871-875 | ||
| 504 | |a Dworkin, L.D., Grosser, M., Feiner, H.D., Ullian, M., Parker, M., The renal vascular effects of antihypertensive therapy in uninephrectornized spontaneously hypertensive rats (1989) Kidney Int., 35, pp. 790-798 | ||
| 504 | |a Salusky, I., Kleinecht, C., Broyer, M., Gubler, M.-C., Prolonged renal survival and stunting with protein-deficient diets in experimental uremia (1981) J. Lab. Clin. Med., 97, pp. 21-30 | ||
| 504 | |a Hostteter, T.H., Olson, J.L., Rennke, H.G., Vankatachalam, M.A., Brenner, B.M., Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation (1981) Am. J. Physiol., 241, pp. F85-F93 | ||
| 504 | |a Blatherwick, N.R., Medlar, E.M., Chronic nephritis in rats fed high-protein diets (1937) Arch. Intern. Med., 59, pp. 572-596 | ||
| 504 | |a Perelstein, E.M., Grunfeld, B.G., Simsolo, R.B., Jiménez, M.I., Gianantonio, C.A., Renal functional reserve compared in haemolytic uraemic syndrome and single kidney (1990) Arch. Dis. Child, 65, pp. 728-731 | ||
| 504 | |a Tufró, A., Arizurrieta, E., Repetto, H., Renal functional reserve in children with a previous episode of hemolytic-uremic syndrome (1991) Pediatr. Nephrol., 5, pp. 184-188 | ||
| 504 | |a Praga, M., Hernandez, E., Montoyo, C., Andrés, A., Ruilope, L.M., Rodicio, J.L., Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria (1992) Am. J. Kidney Dis., 20, pp. 240-248 | ||
| 504 | |a Oldrizzi, L., Rugiú, C., Valvo, E., Lupo, A., Loschiavo, C., Gammaro, L., Tessitore, N., Maschio, G., Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet (1985) Kidney Int., 27, pp. 553-557 | ||
| 504 | |a Giordano, C., Protein restriction in chronic renal failure (1982) Kidney Int., 22, pp. 401-408 | ||
| 504 | |a Klahr, S., Low protein diets and angiotensin-converting enzyme inhibition in progressive renal failure (1993) Am. J. Kidney Dis., 22, pp. 114-119 | ||
| 504 | |a Wingen, A.M., Mehls, O., Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid? (2002) Pediatr. Nephrol., 17, pp. 111-120 | ||
| 504 | |a Hüseman, D., Gellermann, J., Vollmer, I., Ohde, I., Devaux, S., Ehrich, J.H., Filler, G., Hemolytic uremic syndrome and effective plasma flow (1999) Pediatr. Nephrol., 13, pp. 672-677 | ||
| 504 | |a Klahr, S., Levey, A.S., Beck, G.J., Caggiula, A.W., Hunsicker, L., Kusek, J.W., Striker, G., The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease: Modification of Diet in Renal Disease Study Group (1994) N. Engl. J. Med., 330, pp. 877-884 | ||
| 504 | |a Mirkin, B.L., Newman, T.J., Efficacy and safety of captopril in the treatment of severe childhood hypertension: Report of the International Collaborative Study Group (1985) Pediatrics, 75, pp. 1091-1100 | ||
| 504 | |a Heeg, J.E., de Jong, P.E., van der Hem, G.K., de Zeeuw, D., Reduction of proteinuria by angiotensin converting enzyme inhibition (1987) Kidney Int., 31, pp. 78-83 | ||
| 504 | |a Yoshida, Y., Kawamura, T., Ikoma, M., Fogo, A., Ichikawa, I., Effects of antihypertensive drugs on glomerular morphology (1989) Kidney Int., 36, pp. 626-635 | ||
| 504 | |a Proesmans, W., van Wambeke, I., van Dyck, M., Long-term therapy with enalapril in patients with nephrotic-range proteinuria (1996) Pediatr. Nephrol., 10, pp. 587-589 | ||
| 504 | |a Viberti, G., Mogensen, C.E., Groop, L.C., Pauls, J.F., Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria (1994) JAMA, 271, pp. 275-279. , European Microalbuminuria Captopril Study Group | ||
| 504 | |a Delgado, N., Peñalosa, J., Briones, L., Turconi, A., Enalapril therapy in children with renal sequelae of hemolytic uremic syndrome (1992) Pediatr. Nephrol., 6, pp. C165. , (abstract) | ||
| 504 | |a Mann, J.F.E., Reisch, C., Ritz, E., Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function (1990) Kidney Int., 38, pp. 590-594 | ||
| 504 | |a Ravid, M., Lang, R., Rachmani, R., Lishner, M., Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus (1996) Arch. Intern. Med., 156, pp. 286-289 | ||
| 504 | |a Maschio, G., Alberti, D., Janin, J., Locatelli, F., Mann, J.F., Motolese, M., Ponticelli, C., Zucchelli, P., Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency (1996) N. Engl. J. Med., 334, pp. 9939-9945. , and the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study Group | ||
| 504 | |a Remuzzi, G., Tognoni, G., Ruggenenti, P., Perna, A., Long-term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies (1991) J. Nephrol., 3, pp. 193-202. , Gruppo Italiano Studi Epidemiologici in Nefrologia (GISEN) | ||
| 504 | |a Lewis, E.J., Hunsicker, L., Bain, R.P., Rhode, R.D., The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy (1993) N. Engl J. Med., 329, pp. 1456-1462. , for the Collaborative Study Group | ||
| 520 | 3 | |a Renal disease is the most important long-term complication of hemolytic-uremic syndrome (HUS). A comparative study of renal function was carried out in two groups of patients. Group 1 included 19 children followed for a median of 11 years, 1960-1980, with a low-sodium diet, antihypertensive drugs, and a restricted protein intake in the end stage of renal disease. Group 2 included 26 children treated for a median of 9 years, 1988-2002, on a low-sodium diet, early restriction of protein intake according to recommendations, and angiotensin converting enzyme inhibitors (ACEi). Long-term renal function was assessed by the inverse of the plasma creatinine concentration (1/[Cr]) over time. Linear regression lines were fitted to individual values of 1/[Cr] for each child. Regression coefficients of children in group 1 were all negative, ranging from -0.031 to -0.00043; 7 were significantly different from zero, indicating a linear fall in renal function over time. In contrast, children from group 2 had 11 negative slopes (only 1 significant) and 15 positive slopes, ranging from 0.17893 to -0.3899. Fisher's exact test showed that group 1 had significantly more children with negative slopes than group 2. This comparatively better long-term outcome of renal function in children under contemporary treatment was probably associated with early restriction of protein and use of ACEi. © IPNA 2004. |l eng | |
| 593 | |a Nephrology Service, Garrahan Hospital, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina | ||
| 593 | |a Service of Growth/Development, Garrahan Hospital, Buenos Aires, Argentina | ||
| 593 | |a Instituto del Cálculo, Faculdade de Ciencias Exactas, Univesidad de Buenos Aires, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a ANGIOTENSIN CONVERTING ENZYME INHIBITORS |
| 690 | 1 | 0 | |a CHRONIC RENAL FAILURE |
| 690 | 1 | 0 | |a HEMOLYTIC-UREMIC SYNDROME |
| 690 | 1 | 0 | |a HISTORICAL STUDY |
| 690 | 1 | 0 | |a PROTEIN INTAKE |
| 690 | 1 | 0 | |a ANTIHYPERTENSIVE AGENT |
| 690 | 1 | 0 | |a CREATININE |
| 690 | 1 | 0 | |a DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR |
| 690 | 1 | 0 | |a ENALAPRIL |
| 690 | 1 | 0 | |a FUROSEMIDE |
| 690 | 1 | 0 | |a PRAZOSIN |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CHRONIC KIDNEY FAILURE |
| 690 | 1 | 0 | |a CLINICAL ARTICLE |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a CORRELATION COEFFICIENT |
| 690 | 1 | 0 | |a CREATININE BLOOD LEVEL |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a FISHER EXACT TEST |
| 690 | 1 | 0 | |a FOLLOW UP |
| 690 | 1 | 0 | |a HEMOLYTIC UREMIC SYNDROME |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HYPERTENSION |
| 690 | 1 | 0 | |a KIDNEY FUNCTION |
| 690 | 1 | 0 | |a LINEAR REGRESSION ANALYSIS |
| 690 | 1 | 0 | |a LONGITUDINAL STUDY |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN INTAKE |
| 690 | 1 | 0 | |a PROTEIN RESTRICTION |
| 690 | 1 | 0 | |a PROTEINURIA |
| 690 | 1 | 0 | |a SODIUM RESTRICTION |
| 690 | 1 | 0 | |a STATISTICAL SIGNIFICANCE |
| 690 | 1 | 0 | |a ANGIOTENSIN-CONVERTING ENZYME INHIBITORS |
| 690 | 1 | 0 | |a ANTIHYPERTENSIVE AGENTS |
| 690 | 1 | 0 | |a CHILD |
| 690 | 1 | 0 | |a CHILD, PRESCHOOL |
| 690 | 1 | 0 | |a DIET, PROTEIN-RESTRICTED |
| 690 | 1 | 0 | |a DIET, SODIUM-RESTRICTED |
| 690 | 1 | 0 | |a DISEASE PROGRESSION |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a HEMOLYTIC-UREMIC SYNDROME |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a INFANT |
| 690 | 1 | 0 | |a KIDNEY FAILURE, CHRONIC |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a TIME FACTORS |
| 690 | 1 | 0 | |a TREATMENT OUTCOME |
| 700 | 1 | |a Lejarraga, H. | |
| 700 | 1 | |a Kelmansky, D. | |
| 700 | 1 | |a Missoni, M. | |
| 773 | 0 | |d 2004 |g v. 19 |h pp. 1148-1152 |k n. 10 |p Pediatr. Nephrol. |x 0931041X |t Pediatric Nephrology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-4844228028&doi=10.1007%2fs00467-004-1516-y&partnerID=40&md5=56e403074fefd0103f1badc5954e0b4c |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00467-004-1516-y |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_0931041X_v19_n10_p1148_Caletti |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0931041X_v19_n10_p1148_Caletti |y Registro en la Biblioteca Digital |
| 961 | |a paper_0931041X_v19_n10_p1148_Caletti |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 82126 | ||